The significance of lobular neoplasia on needle core biopsy of the breast by S. Menon et al.
ORIGINAL ARTICLE
The significance of lobular neoplasia on needle core biopsy
of the breast
S. Menon & G. J. R. Porter & A. J. Evans & I. O. Ellis &
C. W. Elston & Z. Hodi & A. H. S. Lee
Received: 25 January 2008 /Revised: 28 February 2008 /Accepted: 9 March 2008 /Published online: 4 April 2008
# Springer-Verlag 2008
Abstract The management of a core biopsy diagnosis of
lobular neoplasia is controversial. Detailed radiological–
pathological review of 47 patients with cores showing
classical lobular neoplasia was performed (patients with
pleomorphic lobular carcinoma in situ (LCIS) or associated
risk lesions were considered separately). Immediate surgical
excision in 25 patients showed invasive carcinoma in 7,
ductal carcinoma in situ (DCIS) in 1 and pleomorphic LCIS
in 1; radiological–pathological review showed that the core
biopsy missed a mass in 5, missed calcification in 2 and
that calcification appeared adequately sampled in 2.
Nineteen patients had follow-up of at least 2 years. Four
patients developed malignancy at the site of the core biopsy
(invasive carcinoma in three, DCIS in one); one carcinoma
was mammographically occult, one patient had dense
original mammograms and two had calcifications apparently
adequately sampled by the core. In conclusion, most
carcinomas identified at the site of core biopsy showing
lobular neoplasia were the result of the core missing the
radiological lesion, emphasising the importance of multidis-
ciplinary review and investigation of any discordance. Some
carcinomas were found after apparently adequate core
biopsy, raising the question of whether excision biopsy
should be considered after all core biopsy diagnoses of
lobular neoplasia.
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Introduction
Lobular carcinoma in situ (LCIS) was described by Foot
and Stewart [25]. The term atypical lobular hyperplasia
(ALH) was later introduced to describe a similar lesion, but
with less marked changes. We prefer the term lobular
neoplasia [30], which includes both LCIS and ALH,
particularly for core biopsies in which there is limited
tissue, making distinction between ALH and LCIS difficult.
The relationship between lobular neoplasia and invasive
carcinoma of the breast is controversial [28]. Lobular
neoplasia is often multifocal and bilateral [4]. There is
evidence that it is a risk factor for invasive carcinoma in
both breasts: after a diagnosis of lobular neoplasia, there is
an increased risk of subsequent invasive carcinoma in both
breasts [30], and the majority are ductal in type. Recent
evidence suggests that lobular neoplasia may, like ductal
carcinoma in situ (DCIS), be a non-obligate precursor for
invasive carcinoma at the same site. There is a higher risk
of invasive carcinoma in the ipsilateral than in the
contralateral breast. The proportion of subsequent carcino-
mas that are of lobular type is higher than in unselected
series of carcinomas [45]. The morphology of the cells in
lobular neoplasia and invasive lobular carcinoma is similar.
The same truncating mutation in the E-cadherin gene has
been found in invasive lobular carcinoma and adjacent
LCIS [57].
The significance of lobular neoplasia in breast needle
core biopsies is uncertain. Invasive carcinomas are some-
times identified after a core biopsy diagnosis of lobular
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neoplasia. Some studies suggest this occurs because the
core biopsy missed the lesion and so does not explain the
clinical or radiological abnormality [41]. Other studies
suggest that carcinomas may be identified after the diagnosis
of lobular neoplasia on core biopsy even if the core biopsy
explains the clinical or radiological abnormality [20]. An
important consideration in radiological–pathological correla-
tion is whether classical lobular neoplasia is associated with
calcification. The traditional view is that lobular neoplasia
does not have a radiological correlate [4], but recent reports
have described an association between classical lobular
neoplasia and calcification. We also wished to investigate
our impression that, in core biopsies containing classical
lobular neoplasia, calcification is often associated with
columnar cell change.
Pleomorphic LCIS is a recently described variant of lobular
neoplasia. The growth pattern and absence of E-cadherin
expression resemble classical LCIS. However, the marked
nuclear pleomorphism, frequent presence of central necrosis
and calcification and expression of c-erbB-2 are similar to
high-grade DCIS [50]. In the past, pleomorphic LCIS would
usually have been diagnosed as high-grade DCIS.
The main aim of this study was to assess the risk of
invasive carcinoma and DCIS at the site of classical lobular
neoplasia diagnosed on breast needle core biopsies. In view
of the clear morphological differences, pleomorphic LCIS
was considered separately. A second aim was to investigate
the localisation of calcification in core biopsies containing
lobular neoplasia.
Materials and methods
This project was discussed with the chair of the Nottingham
University Hospitals Research Ethics Committee who
considered that it was a service evaluation and, therefore,
did not require formal ethical approval. A multidisciplinary
review of the pathology and radiology of patients with a
core biopsy diagnosis of lobular neoplasia from July 1998
to June 2006 was performed. The biopsies from July 1998
to June 2000 were included in a previous study [35]. The
diagnosis of lobular neoplasia was made on haematoxylin
and eosin sections. Immunohistochemistry for E-cadherin
was performed for lesions with a differential diagnosis
including DCIS or pleomorphic LCIS. Lobular neoplasia
was subdivided into ALH and LCIS using the criteria
described by Page et al. [44]. Pleomorphic LCIS was
defined as a high-grade dyscohesive intra-acinar proliferation
that was E-cadherin negative.
Patients were excluded if they had synchronous or
previous invasive carcinoma or DCIS in the same breast.
Two patients with contralateral invasive carcinoma were
included. Core biopsies containing invasive carcinoma,
DCIS or an area suspicious of either diagnosis were
excluded. Cores containing pleomorphic LCIS, an atypical
intraductal epithelial proliferation (including atypical ductal
hyperplasia), radial scar or a papillary lesion were considered
separately. Thus, the main group of core biopsies studied
contained classical lobular neoplasia with no other risk
lesions: we termed this group “simple” classical lobular
neoplasia.
The core biopsies were reviewed for the following
features: location of any calcification and presence of
columnar cell change. Six cores were not available, so
could not be reviewed. The frequency of columnar cell
change was compared with 87 consecutive core biopsies
reported by one observer (AHSL) as normal or benign.
Results
Simple classical lobular neoplasia on core biopsy
Forty-nine core biopsies with lobular neoplasia from 47
women satisfied the entry criteria (0.3% of the 14,597
diagnostic core biopsies performed during this period). Two
patients had two core biopsies from the same area of the
breast containing lobular neoplasia: both are only counted
once in the following results. The median age was 52 years
(range 33 to 81).
Twenty-six patients presented with mammographic
screening abnormalities: 20 with calcification, 3 with a mass,
2 with calcification and distortion and 1 with a mass and
calcification. Nineteen patients presented symptomatically:
ten with a mass, seven with a thickening and two with a
thickening and calcification. Two women had calcification
identified by mammography performed in one patient as part
of the investigation of a contralateral carcinoma and, in the
other, as follow-up of a contralateral carcinoma. Eight core
biopsies were freehand, 14 were ultrasound guided and 25
were performed under stereotactic guidance.
There was an association between lobular neoplasia and
columnar cell change (see Table 1). Calcification was seen
in 25 of 41 cores with slides available for review. It was
seen in lobular neoplasia in six biopsies (15%); in one the








None 12 (29%) 58 (67%)
One lobule or duct 9 (22%) 14 (16%)
At least two lobules or
ducts
20 (49%) 15 (17%)
χ2 =18, P=0.0001
474 Virchows Arch (2008) 452:473–479
calcification was only seen in the lobular neoplasia, but in
the other five, it was also present in other changes
(columnar cell change in three, sclerosing adenosis in one,
fibroadenoma in one). Of the other 19 biopsies with
calcification, columnar cell change was the most commonly
associated pathology (10 biopsies).
Surgical excision within 2 months of core biopsy was
performed in 25 patients. Excision showed malignancy in
nine patients (see Table 2). In seven patients, pathology–
radiology correlation showed that the core biopsy did not
explain the radiological abnormality (a mass in five and
calcification in two). Five of these seven patients were seen
in the first 2 years of this study. Excision showed benign
changes in 16, although one woman had invasive carcino-
ma of mixed ductal and lobular type diagnosed 33 months
after the core biopsy in a separate quadrant of the same
breast.
Nineteen patients who had not had a diagnostic surgical
excision had follow-up of at least 2 years (range 25 to
105 months). None of these patients received radiotherapy
to the breast. Malignancy was identified in seven women.
In four, the malignancy was at the same site as the core
biopsy (see Table 2), in one DCIS was found in a different
quadrant of the same breast and two developed contralateral
invasive carcinoma. Three women had no surgical excision
and follow-up of less than 2 years. Neither of the two
women with a previous history of contralateral invasive
carcinoma developed carcinoma at the site of the core
biopsy showing lobular neoplasia.
No significant relationships were found between the
diagnosis of malignancy (DCIS, pleomorphic LCIS or
invasive carcinoma) at the site of the core biopsy and the
following features: age of the woman, diagnosis of ALH or
LCIS on the core biopsy, whether core biopsy or vacuum-
assisted biopsy was performed and the method of guidance
(freehand, ultrasound or stereotactic).
Pleomorphic LCIS on core biopsy
Both patients with pleomorphic LCIS on core biopsy
presented with calcification detected by mammographic
screening. In both, calcification was seen histologically in
association with the pleomorphic LCIS. Both had a
diagnostic surgical excision, which showed cribriform
DCIS in one and further LCIS in the other.
Atypical intraductal epithelial proliferation/radial
scar/papillary lesion
Eight patients had atypical intraductal epithelial proliferation,
radial scar or a papillary lesion in addition to lobular neoplasia






Final diagnosis (surgical procedure) Pathology–radiology
correlation
60 Screen-detected mass ALH, CCCh, calcs 1 13 mm IDC, G3, LN 0/4 (Mx) Core missed mass
75 Symptomatic mass LCIS, UEH, CCCh 2 6 mm IDC, G2, LN not examined (Mx) Core missed mass
63 Screen-detected distortion and
calcification. Mass on US
ALH 1 14 mm ILC, G2, LN 0/5 (WLE) Core missed mass
54 Screen-detected calcification ALH 1 4 mm tubulobular carcinoma G1 +
50 mm DCIS, LN 0/6 (Mx)
Core missed calcs
43 Symptomatic mass LCIS 1 9 mm IDLC, G2, LN 0/7 (Mx) Core missed mass
68 Screen-detected mass ALH 1 12 mm ILC, G2, LN 0/6 (Mx) Core missed mass
64 Symptomatic mass, no mass on US.
Mammographic calcification
ALH, cyst, calcs 1 7 mm DCIS (WLE) Calcs sampled by core
54 Screen-detected calcification ALH 1 12 mm tubular carcinoma + 35 mm
DCIS, LN 0/4 (WLE)
Core missed calcs
45 Symptomatic cysts. Mammographic
calcification
LCIS, calcs 1 5 mm pleomorphic LCIS (WLE) Calcs sampled by core
52 Screen-detected calcification ALH, UEH,
CCCh, calcs
31 9 mm ILC, G2, LN 1/6 (Mx) Mammographically
occult mass
70 Screen-detected calcification ALH, calcs 29 36 mm IDC, G3, LN 6/16 (Mx) Dense original
mammogram
51 Screen-detected calcification ALH, CCCh, calcs 26 30 mm DCIS + extensive LCIS (Mx) Calcs sampled by core
55 Screen-detected calcification ALH, CCCh, calcs 29 IDC 8 mm, G3, 45 mm DCIS, LN 1/4 (Mx) Calcs sampled by core
US ultrasound, ALH atypical lobular hyperplasia, LCIS lobular carcinoma in situ, UEH epithelial hyperplasia of usual type, CCCh columnar cell
change, calcs calcification, IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, IDLC invasive ductal and lobular carcinoma, DCIS
ductal carcinoma in situ, G histological grade, LN axillary lymph nodes, Mx mastectomy, WLE wide local excision
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on the core biopsy. All eight presented with abnormalities
detected by mammographic screening: calcification in five,
calcification and distortion in one, mass in one and distortion
in one. Seven patients had a diagnostic surgical excision, and
one patient had her lesion removed with vacuum-assisted
mammotomy. DCIS was found in one of three women with
core diagnosis of atypical intraductal epithelial atypia and in
one of two with core diagnosis of radial scar. Papillary DCIS
with a 3-mm focus of invasion was found after a core
diagnosis of papillary lesion with atypical intraductal epithe-
lial proliferation. One patient with a core diagnosis of radial
scar with atypical intraductal epithelial proliferation and one
with a papillary lesion had benign findings at excision.
Discussion
Relation between lobular neoplasia and calcification
An important question in the management of lobular
neoplasia on core biopsy is the relationship between lobular
neoplasia and calcification. Lobular neoplasia is not
typically associated with any specific clinical abnormality,
and there are no characteristic macroscopic features. Early
papers suggested that classical lobular neoplasia does not
have any diagnostic mammographic features [4]. In the
past, surgical biopsies containing lobular neoplasia were
frequently performed for mammographic calcification, but
pathologically, the calcification was mostly associated with
fibrocystic change and identified within the lobular neoplasia
in about 20% [4, 11, 24, 55]. Calcification is associated with
the lobular neoplasia in between 8% and 53% of core
biopsies containing classical lobular neoplasia in different
studies [1, 3, 14, 20, 41]. Benign calcification is frequently
seen close to invasive carcinomas in surgical specimens [52].
It is well recognised that malignancy may be an incidental
discovery on a biopsy for calcification that is associated only
with benign disease [49].
The present study confirms the association between
lobular neoplasia and columnar cell change [8, 41]. In older
studies, the majority of surgical biopsies containing lobular
neoplasia were performed for fibrocystic change [30]. In
the present study, calcification was associated with lobular
neoplasia in 15% of core biopsies, but commonly was also
seen in fibrocystic change as well. Calcification was
associated with columnar cell change in 32% of cores with
lobular neoplasia. The association of calcification with
columnar cell change is well recognised [27]. Our results
support the view that, in biopsies containing lobular
neoplasia, most of the calcification is associated with
fibrocystic change, particularly columnar cell change.
Importantly, the lobular neoplasia is incidental to the
calcification in the majority of biopsies.
A recent study of collagenous spherulosis found that 15
of 59 patients had associated LCIS [48]. In contrast, only
one of the patients in the present study with lobular
neoplasia had associated collagenous spherulosis.
Relationship between simple classical lobular neoplasia
and carcinoma
In this study, 44 women with simple classical lobular
neoplasia on core biopsy had surgical excision or follow-up
of at least 2 years. Twenty-five women had immediate
surgical excision, which showed invasive carcinoma, DCIS
or pleomorphic LCIS in nine (36%). In the majority, the
core biopsy was judged to have missed the clinical/
radiological lesion. This emphasises the importance of
clinico-pathological review and further investigation of any
discordance. Most of the missed lesions occurred in the
early part of the study, suggesting that the accuracy of
radiological localisation of core biopsies may have im-
proved later in the series. A smaller number of carcinomas
occurred after lobular neoplasia on core biopsy apparently
incidental to the clinical or radiological lesion. This raises
the question of whether excision biopsy should be
considered after all core biopsy diagnoses of lobular
neoplasia. The frequency of malignancy if the patients with
radiological–pathological discordance are excluded is 11%
(2/18).
Four of 19 patients with at least 2 years follow-up
developed carcinoma at the site of the core biopsy. In one,
the carcinoma was mammographically occult, although it
was clinically palpable, in one the original mammogram
was dense and two women had calcification apparently
adequately sampled by the core biopsy. Definite comment
cannot be made, but the clinical histories suggest that it is
possible that the carcinoma may have been identified earlier
in some of these patients if they had had an immediate
surgical biopsy. If these women are added to those without
radiological–pathological discordance in the above para-
graph, the frequency of malignancy is 16% (6/37).
Previous published studies of simple lobular neoplasia
on core biopsy were reviewed [1–3, 6, 9, 10, 12, 14, 16–18,
20, 21, 23, 25, 26, 31, 33, 36, 37, 39, 41–43, 46, 47, 51, 54,
58, 59]. The data in most studies are not representative.
Probably the major bias is that only about half of the
lesions had a surgical biopsy and it is not clear how patients
were selected for excision biopsy. Furthermore, most
studies only report image-guided or stereotactic biopsies.
A surgical biopsy was performed in 561 patients with a
core biopsy diagnosis of lobular neoplasia with invasive
carcinoma found in 50 or 49 and DCIS in 32 or 33 (82
[15%] in total). It is ‘impossible to know if some of the
reported cases are those in which the targeted lesion has
been missed and re-excision was done for failure to
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successfully sample the target’ [15]. In reviewing the
previous studies, we have assumed that sampling was
adequate for core biopsy performed for calcification if
calcification was present in the core biopsy. Of those 52
malignancies with details available, 25 (48%) had a
radiological–pathological discordance (missed mass in 22
and missed calcification in 3), and 27 had apparently
adequately sampled calcification.
One hundred four patients who did not have immediate
surgical excision had reported follow-up. The only four
patients (4%) with invasive carcinoma or DCIS on follow-
up at the site of core biopsy are the four patients described
in the present study. The absence of subsequent malignancy
in other studies is very surprising given that lobular
neoplasia is a well-established risk factor for later carcinoma.
Nevertheless, the low rate suggests that the chance of
invasive carcinoma or DCIS is lower in those not having
immediate surgical excision.
It is difficult to estimate the chance of finding invasive
carcinoma or DCIS if all patients had an excision biopsy. The
15% rate found in the subset of patients who had immediate
excision biopsy is probably an overestimate. If the cases with
radiological–pathological discordance are excluded, the risk
is probably about half of this, approximately 8%. If one
assumes that half of the patients who did not have an
immediate excision did not have invasive carcinoma or
DCIS at the core site, this gives an estimate of about 4%.
This represents an estimate of the lower limit of risk.
Some studies suggest that the risk of finding invasive
carcinoma or DCIS is a little higher if the core biopsy
shows LCIS rather than ALH [13]. In view of the
subjectivity of this distinction on core biopsy, it is probably
of limited use in routine practice.
It is clearly appropriate to investigate patients with
simple classical lobular neoplasia on core biopsy that does
not explain the clinical or radiological abnormality. If a
definitive diagnosis cannot be made with further core
biopsy, then an excision biopsy is indicated.
The management of simple classical lobular neoplasia on
core biopsy with no radiological–pathological discordance
is less straightforward. As discussed above, the literature
suggests that the risk of malignancy is in the range of 4% to
8%. This risk is comparable to that associated with radial
scar or papillary lesion with no epithelial atypia [7, 34, 35,
40, 53]. Both radial scars and papillary lesions are excised
in many centres according to current guidance [19]. The
major difference with lobular neoplasia, however, is that
both are usually clearly defined lesions on radiological
examination and therefore easy to excise.
There is a need for prospective studies with surgical
excision of all lesions so that an unbiased assessment of the
risk of simple classical lobular neoplasia on core biopsy can
be made. Careful radiology–pathology correlation is essential.
It may be possible to stratify the risk within this group using
clinical, radiological or pathological features.
Lobular neoplasia associated with radial scars, papillary
lesions and atypical intraductal epithelial proliferations
Most centres excise radial scars, papillary lesions and
atypical intraductal epithelial proliferations diagnosed on
core biopsy. In the present study, carcinoma was found on
excision of three of the eight lesions with these lesions in
combination with lobular neoplasia. This supports the
practice of excising such lesions.
Pleomorphic LCIS
In the present study, both cores with pleomorphic LCIS had
associated calcification. In contrast to the controversial
nature of the association between calcification and classical
LCIS, the literature suggests that there is a clear relation-
ship between calcification and pleomorphic LCIS [29, 50].
There are limited data on the significance of pleomorphic
LCIS on core biopsy. One of the two patients in the present
study had DCIS in the excision specimen. Three of the six
patients described in the literature [5, 20, 37] had invasive
carcinoma on excision, but radiology showed a density in
one and an architectural distortion in another. Although the
follow-up data are limited, we believe that, until there is
further evidence, it is prudent to recommend that pleomor-
phic LCIS is managed as DCIS because of the morpholog-
ical similarity of pleomorphic LCIS to high-grade DCIS.
The present study may underestimate the frequency of
pleomorphic LCIS, as E-cadherin immunohistochemistry
was infrequently performed early in the study period and
some cases may have been diagnosed as high-grade
DCIS.
Some lobular neoplasia shows features overlapping with
DCIS and is difficult to classify even with E-cadherin
immunohistochemistry [32, 38]. Lobular neoplasia with
comedo necrosis, but without marked nuclear pleomorphism,
has recently been described [22]. The clinical significance of
these rare clinico-pathological scenarios is uncertain. Until
there is more evidence, it would be prudent to recommend
surgical biopsy of such lesions because of the overlap of
features with DCIS. Mass forming lobular neoplasia can
occur rarely [56], but is an example of clinico-pathological
discordance, so surgical biopsy is prudent.
In conclusion, we recommend excision after a core
biopsy diagnosis of lobular neoplasia in the following
circumstances:
1. Discordance of clinical or radiological findings with the
pathological changes (this includes mass-forming lobular
neoplasia)
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2. Lobular neoplasia with atypical histological features
including pleomorphic LCIS, lobular neoplasia with
necrosis, and when it is not possible to exclude DCIS
despite E-cadherin immunohistochemistry
3. If there is an associated risk lesion, such as atypical
intraductal epithelial proliferation, radial scar or papil-
lary lesion.
We suggest that further studies are needed to guide the
management of simple classical lobular neoplasia, as the
data on the risk of associated carcinoma remain unclear in
this group of patients.
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